VTYX - CIK 0001851194
Ventyx Biosciences, Inc. (VTYX) reported net income of -$135.12M for fiscal year 2024, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2024 | -$135.12M | +30.0% |
| FY 2023 | -$192.96M | -78.0% |
| FY 2022 | -$108.43M | -29.5% |
| FY 2021 | -$83.75M | -197.2% |
| FY 2020 | -$28.17M | - |
Ventyx Biosciences, Inc. (VTYX) reported net income of -$135.12M for fiscal year 2024, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2024, Ventyx Biosciences, Inc.'s net income declined from -$28.17M to -$135.12M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.